• ABOUT US
  • PATENT SERVICES   
    • Drafting & Filing
    • Prosecution
    • Analytics & IP Strategy
    • IP Awareness
    •  
  • TEAM
  • IP KNOWLEDGE
  • FAQs
  • CAREERS
  • CONTACT
IP KNOWLEDGE
  • Articles
  • IP Speak
  • IP Bulletin
  • PTO Update
Saturday, 5th July 2025

Articles
― Friday, 12th June 2020
Availing Patent Benefits – A ‘Status’ Check!

Every patent office provides certain benefits to Patent Applicants if they meet certain criteria (with respect to entity size, gross income and others). These benefits may be patent fee discounts or speedy examination processes.

This article touches upon the benefits extended by IPO, USPTO and EPO to entities based on their status. 

-IPproTeam  

#Patent101, #Patent Office, #Indian Patent Office, #IPO, #USPTO, #Patent Filing, #Filing, #Invention, #Start-up #Startup, #Entrepreneur, #MSME, #SMEs, #Micro Entity, #Small Entity, #Non-Profit, #University, #Public Research, #DPIIT       


READ MORE
― Wednesday, 27th May 2020
Not an Equal world for AI - No Inventorship for them!

With Artificial intelligence (AI) replacing humans in myriad sectors and operational aspects, it is not surprising that AI is able to concoct its own inventions. AI-generated inventions are (and may become) the norm, however, awarding inventorship to AI under the current patent system is far-fetched. So, is it justifiable denying patent rights to the actual inventor for inventions created by AI or does the patent system merely operate on the fact that AI is a machine with no capability to exercise legal rights even if given any, and therefore unfit to hold inventorship for its creations.

-Authors: Nethravathi D | Abhijith Paipad

#AI as Inventor, #AI, #Artificial Intelligence, #Invention, #Inventorship, #AI Creations, #IPO, #Indian Patent Office, #USPTO, #EPO, #CNPO, #KIPO, #JPO, #Patent Rights

READ MORE
― Wednesday, 27th May 2020
First Filing in India: A Requirement or a Choice?

Indian resident inventors may decide to file patent applications in multiple countries including India or entirely disregard India and go international! This may be due to weak market strength/poor demand for the product/invention in the country.

As per Indian Patents Act, it is mandatory to obtain an Foreign Filing License (FFL) if an Indian resident inventor decides to first file in a foreign country bypassing Indian Patent Office(IPO) . As per the rules, within 21 days of requesting for an FFL, the IPO, usually, either issues the FFL certificate or rejects the FFL request.

Another option is to first file in India and then wait for a cooling-off period (six weeks!) before attempting to file in a foreign country. In this case, an FFL is not required.

-IPproTeam

#Patent101, #FFL, #First Filing, #Patent Office, #Foreign Filing License, #Indian Patent Office, #IPO, #Indian Resident,           # Patent Filing, #Filing, #Invention, #Technology, #Secrecy Provision 

READ MORE
― Friday, 22nd May 2020
The Missing Link - IT Act and IPR Laws

Cyber laws are defined under the Information Technology (IT) Act of 2000 encompassing legal and regulatory aspects of the internet and the world wide web. However, certain entities/intermediaries such as e-commerce websites, search engines, and data aggregators sometimes come under scrutiny for violation of IPR laws when seen under the light of IT Act. Hence, protection to intermediaries from liability, arising out of content posted by users, needs be addressed by creating nexus between IT Act and IPR laws.

-Author: Abhijith Paipad

#Informationtechnology,  #copyright,  #Trademark,  #infringment,  #IPR,  #ITact,  #DMCA,  #intermediary,  #intellectualproperty,  #cyberlaw

READ MORE
― Wednesday, 20th May 2020
Keeping an Eye on India - USA’s IP Priority Watch List

India has been grappling with big IP giants such as the US to establish its stance on the IP front. Owing to a fallible IP regime, India has yet again come under the US’s Priority Watch List and is required to meet certain expectations of the US in terms of trade and other IPR related policies. However, the question still remains whether India, being a sovereign nation, should let itself be subdued by the US or have its own say in IP matters concerning the nation. 

-Author: Emily Premkumar

#IPwatchlist, #Prioritywatchlist, #USA, #India, #IndiaPatentOffice, #IPO, #Patent, #PatentFiling, #PatentEnforcement, #CompulsoryLicensing 

READ MORE
LOAD MORE
Saturday, 5th July 2025

IP Speak
― Friday, 4th July 2025
Music Special: Views on AI, creators' rights and IP developments
READ MORE
― Friday, 4th July 2025
Fair use or foul play? The AI fair use copyright line
READ MORE
― Friday, 4th July 2025
The IP game India must learn to win
READ MORE
― Thursday, 3rd July 2025
Boxing Out Competitors: WNBA Star Angel Reese’s Growing Trademark Portfolio
READ MORE
― Thursday, 3rd July 2025
Ratio: The Good and Bad in the First Two American Decisions on Generative AI and Copyright
READ MORE
LOAD MORE
Saturday, 5th July 2025

Current News
― Friday, 4th July 2025
Supreme Court Grants Cert in First (and only) IP Case of 2024: Billion-Dollar ISP Copyright Contributory Liability Case
Supreme Court granted certiorari in Cox Communications, Inc. v. Sony Music Entertainment, No. 24-171, while denying the competing petition in Sony Music Entertainment v. Cox Communications, No. 24-181. 
READ MORE
― Friday, 4th July 2025
Did They Want to Infringe? – Federal Circuit Denies Declaratory Judgment When Party at No Risk of Lawsuit
Mitek Systems, Inc. (Mitek) sought declaratory judgment that its software product did not infringe three United Services Auto Association (USAA) patents. 
READ MORE
― Friday, 4th July 2025
Cigna Sues Bristol Myers Squibb Alleging Scheme to Block Generic Drug
Cigna alleges that Celgene violated U.S. antitrust laws by engaging in a years-long scheme to maintain its monopoly over the treatment of multiple myeloma.
READ MORE
― Thursday, 3rd July 2025
CAFC Says Prosecution History Shows Board Erred in Construction of Eye Treatment Patent Claim Term
On Monday, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential ruling in Eye Therapies, LLC v. Slayback Pharma, LLC, vacating an obviousness ruling by the Patent Trial and Appeal Board (PTAB) that invalidated Eye Therapies’ patent claims to methods of treating eye redness. 
READ MORE
― Thursday, 3rd July 2025
Amgen Files BPCIA Complaints Against Biocon, Shanghai Henlius/Organon and Hikma/Gideon Richter Regarding Denosumab Biosimilars
Amgen filed a complaint in the U.S. District Court for the District of New Jersey against Hikma Pharmaceuticals USA Inc. (“Hikma”), Gedeon Richter Plc., and Gedeon Richter USA, Inc. (collectively, “Gedeon”), alleging that their denosumab biosimilars, RGB-14-P and RGB-14-X, will infringe 32 patents.
READ MORE
LOAD MORE
Saturday, 5th July 2025

Patent Office Update
― Friday, 4th July 2025
OLAF and EUIPO join forces to fight counterfeits in everyday products
READ MORE
― Thursday, 3rd July 2025
CNIPA Deputy Commissioner Attends the Closed-Door Policy Meeting on Intellectual Property at the Sixth Qingdao Multinationals Summit
READ MORE
― Wednesday, 2nd July 2025
Ireland-EPO agreement ‘beneficial’ for IP innovation and protection
READ MORE
― Tuesday, 1st July 2025
How the USPTO Could Make a Permanent After-Final Consideration Program Work
READ MORE
― Monday, 30th June 2025
USPTO Newest Discretionary Denials on Settled Expectations — Best Practices for Petitioners and Patent Owners
READ MORE
LOAD MORE
                         
Site map                 Follow us   Offices  



About Us Team Articles IP Updates FAQs Careers
 
  Bangalore Silicon Valley
Who are we                   102, Prestige Loka,
7/1, Brunton Road,
Bangalore- 560 025, INDIA.

220 California Ave,
Suite 201, Palo Alto,
CA- 94306, USA.
What we do                    
Industry Expertise                    
                      +91 80 6693 5000 +1 650 325 7100
Services                        
Patent Drafting & Filing Patent Prosecution Patent Analytics & IP Strategy IP Awareness Initiatives   Get in touch

  Mumbai Singapore
Prior Art Search Patent Prosecution Patent Invalidation Search Workshops & Seminars  
Patent Drafting Services Patent Litigation Support Freedom-To-Operate Analysis Daily bulletin  
ENQUIRE
  93-B Mittal Court,
Nariman Point,
Mumbai- 400 021,
INDIA.

Level 30,
Six Battery Road,
Singapore- 049909.
Patent Filing Services       Landscape Analysis Research Articles    
        State of the art Search      
        IP Watch      
        IP Due Diligence         +91 22 6669 5000 +65 6550 9855
Copyrights © 2016 IPpro Services (India) LLP. All rights reserved.            

Success !